Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study-Reference-Cited by-同舟云学术

Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study

Published:2018-04 Issue:2 Volume:16 Page:135-141.e1
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Inoue Takahiro,Mizowaki Takashi^ORCID,Kabata Daijiro,Shintani Ayumi,Terada Naoki,Yamasaki Toshinari,Negoro Hiromitsu,Kobayashi Takashi,Nakamura Kiyonao^ORCID,Inokuchi Haruo,Ogawa Osamu

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference23 articles.

1. Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: a systematic review of the literature;Zilli;Cancer Treat Rev,2016

2. Adverse effects of androgen deprivation therapy and strategies to mitigate them;Nguyen;Eur Urol,2015

3. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners;Donovan;Cancer,2015

4. Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer;Shahidi;Clin Oncol (R Coll Radiol),2001

5. Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer;Padula;Int J Radiat Oncol Biol Phys,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of Delayed Testosterone Recovery in Patients with Prostate Cancer;European Urology Open Science;2024-02

2. Deep reinforcement learning identifies personalized intermittent androgen deprivation therapy for prostate cancer;Briefings in Bioinformatics;2024-01-22

3. Testosterone as a Biomarker for Quality of Life (QOL) Following Androgen Deprivation Therapy (ADT) and Stereotactic Body Radiotherapy (SBRT);Cureus;2023-08-31

4. Differences in sex hormone recovery profile after cessation of 12‐week gonadotropin‐releasing hormone antagonist versus agonist therapy;Andrology;2021-09-24

5. Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy;International Journal of Clinical Oncology;2021-06-04